郭家伟，长江大学医学部药理教研室，副教授，硕士生导师，湖北省楚天学者，湖北省第二届医学青年拔尖人才，广东省优秀学生，中山大学优秀博士学位论文。

2020年获中山大学药理学博士学位。主要从事心血管及代谢性疾病研究，近年来主持国家自然科学基金、湖北省自然科学基金等项目，近年来以第一或通讯作者在European Heart Journal(IF=37.6), Advanced Science (IF=14.3), Cell Death Disease (IF=8.1),等高水平杂志发表多篇论著。

电子信箱：guojw9@mail2.sysu.edu.cn

代表性论著：

1）Guo JW#, Liu X#, Zhang TT#, Lin XC#, Hong Y, Yu J, Wu QY, Zhang FR, Wu QQ, Shang JY, Lv XF, Ou JS, Zhou JG, Pang RP*, Tang BD*, Liang SJ*. Hepatocyte TMEM16A Deletion Retards NAFLD Progression by Ameliorating Hepatic Glucose Metabolic Disorder. Adv Sci (Weinh). 2020 Mar 20;7(10):1903657. (SCI, IF=15.1)

2）Liu X#, Guo JW#, Lin XC#, Tuo YH#, Peng WL#, He SY, Li ZQ, Ye YC, Yu J, Zhang FR, Ma MM, Shang JY, Lv XF, Zhou AD, Ouyang Y, Wang C, Pang RP, Sun JX, Ou JS*, Zhou JG*, Liang SJ*. Macrophage NFATc3 prevents foam cell formation and atherosclerosis: evidence and mechanisms. Eur Heart J. 2021 Dec 14;42(47):4847-4861. (SCI, IF=39.3)

3）Guo J#*, Song Z#, Yu J#, Li C, Jin C, Duan W, Liu X, Liu Y, Huang S, Tuo Y, Pei F, Jian Z, Zhou P, Zheng S, Zou Z, Zhang F, Gong Q*, Liang S*. Hepatocyte-specific TMEM16A deficiency alleviates hepatic ischemia/reperfusion injury via suppressing GPX4-mediated ferroptosis. Cell Death Dis. 2022 Dec 26;13(12):1072. (SCI, IF=8.1)

4）Li C#, Song Z#, Gao P#, Duan W, Liu X, Liang S, Gong Q#, Guo J#. Transaldolase inhibits CD36 expression by modulating glutathione-p38 signaling, exerting protective effects against macrophage foam cell formation. Acta Biochim Biophys Sin (Shanghai). 2023 Aug 1;55(9):1496-1505. (SCI, IF=3.3)

5）Zou Z#, Liu X#, Yu J#, Ban T#, Zhang Z, Wang P, Huang R, Zheng F, Chang Y, Peng W, Tang Y, Feng X, Zhao Z, Lv X, Huang S, Guo J, Tuo Y, Zhou Z, Liang S*. Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice. J Hepatol. 2024 Feb 6:S0168-8278(24)00107-7. (SCI, IF=26.8)

本课题组长期招聘硕士研究生。有意者欢迎与我联系：guojw9@mail2.sysu.edu.cn。热烈欢迎国内外优秀人才加入我们！